Status:
COMPLETED
A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)
Lead Sponsor:
Yonsei University
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
20-74 years
Phase:
NA
Brief Summary
This randomized trial explored whether digital media (videos and chatbots) used for patient education could more effectively reduce anxiety in breast cancer patients during radiation therapy, compared...
Detailed Description
This study evaluates the impact of patient management and information provision using educational videos and chatbots on patient experience, satisfaction, and patient psychology in the breast cancer r...
Eligibility Criteria
Inclusion
- A breast cancer patient scheduled for radiation therapy after radical surgery.
- Subjects must have the cognitive ability to use smartphone.
- Age ≥ 20 year old
Exclusion
- Patients with visual or auditory impairment.
- Subjects do not consent to participate in this study.
- Pregnancy, fetus, newborn, underage
- Age ≥ 75 year old
Key Trial Info
Start Date :
April 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2023
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT06207474
Start Date
April 18 2022
End Date
April 18 2023
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei Cancer Center
Seoul, South Korea